Is Rhythm Biosciences Limited a good investment? Rhythm Biosciences Limited (RHY.AX) is currently trading at 0.0980 AUD.
Earnings Schedule: Rhythm Biosciences Limited is expected to release its next earnings report on Feb. 24, 2027.
No, it does not currently pay a dividend.
Rhythm Biosciences Limited is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
The next earnings date is projected to be Feb. 24, 2027. The company currently has a trailing EPS of -0.04.
Rhythm Biosciences Limited, engages in developing and commercializing medical diagnostics technology in Australia and internationally. It develops ColoSTAT, a blood test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Parkville, Australia.
Community Discussion